Essential reading for the healthcare business
Remember me:
Skip Navigation LinksHealthInvestor article
NHS tenders out £1.2bn Staffordshire contract

Healthcare providers have been invited to bid for two, ten-year NHS contracts, worth £1.2 billion in total, to provide frontline cancer treatment and care for the terminally ill across Staffordshire.
Run by the NHS Strategic Projects Team, the move is the NHS’s biggest outsourcing exercise yet and provides significant opportunity for the private sector to become involved in the delivery of NHS services.
The contracts cover cancer and end-of-life treatment for children and adults in Staffordshire, and include services such as radiology, radiotherapy, breast screening, chemotherapy, surgery and nursing in hospital, hospice and home settings.
The first contract, worth £687 million, is for the provisions of cancer services in Staffordshire, and the other, worth £535 million, covers end of life care for the elderly in the county.
Winning bidders will run the contracts on a ‘prime provider’ model that will see one organisation oversee the programme and employ sub-contractors to help it carry out the service.
Macmillan Cancer Support and four clinical commissioning groups in the Staffordshire region have been working together on shaping the delivery of the outsourced services.
“By appointing one sole provider to be responsible for each of the whole cancer and end-of-life pathways from beginning to end, rather than the current system of a number of providers with a series of contracts for each separate part of the care pathway… we should be able to get better service for everyone,” said Macmillan.  
Due to their scope and duration, the NHS has given these contracts ‘pioneer’ status.
Shadow health secretary Andy Burnham said: “It is clear that ministers are determined to force ever-larger and more valuable contracts out to the open market.
“David Cameron has placed the NHS on a fast track to fragmentation and privatisation. The next election presents the last chance to change course.”

Related articles:

Posted on: 17/03/2014

Latest news stories

Private equity house Livingbridge is on the verge of acquiring a 30% stake in home care provider Helping Hands, HealthInvestor UK understands.
Around 1.3 million NHS employees are in line for a pay increase of 6.5% or more over three years, it has been confirmed.
Auckland-based ehealth software company Orion Health has been commissioned by the four health boards in the North of Scotland – NHS Highland, NHS Grampian, NHS Orkney and NHS Shetland – a to build a new web-based portal.
Jeremy Hunt has indicated that a cap on social care costs paid by individuals may be pending, after saying that dementia sufferers should not be hit by ‘punitive’ costs.
Group operating profit fell 6% at Mears Group to £39.2 million, compared with £41.9 million in 2016, the results for the year to 31 December 2017 show.


Christie + Co

my images

interview: Adrian Stevensen
One Healthcare CEO Adrian Stevensen tells Ploy Radford how the new provider is overcoming the barriers to entry in the UK private hospital market
Read more

private finance initiative

The collapse of Carillion may have scuppered PF2's chances of survival. Mark Hellowell investigates
Read more

HealthInvestor blog
Spire’s new boss has unveiled his plans to restore the hospital group’s ailing fortunes and share price

Click here to view the Editor's blog

... is a problem halved? Clare Connell and Ryan Perrott analyse whether the Shared Lives scheme is the most effective method for moving more care into the community
Pauline Issard recounts how she harnessed technology to combat frustrations with equine health issues
BGF has backed a one-of-a-kind business bridging the gap between hospitals with blocked beds and social care providers
A new IVF clinic from the team behind CREATE Fertility plans to make treatment more affordable, transparent and accessible, with a ‘shoebox’ technique at its core. Sarah Williams speaks to abc ivf chief executive Praful Nargund
The collapse of Carillion may have scuppered PF2’s chances of survival. Mark Hellowell investigates

Click here to search all feature articles